| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | HAE Haemonetics Corp | Strong Stewart W67 | President, Global Hospital | Sell | 8,857 | $87.53 | $775,253.21 | -32.7% | -12.3% | -22.5% | |
| May 29, 2024 | ISRG Intuitive Surgical Inc | Desantis Robert49 | EVP &Chief Strategy &Corp Op | Sell | 772 | $402.51 | $310,734.36 | -3.4% | +21.1% | +39.5% | |
| May 28, 2024 | BSX Boston Scientific Corp | Butcher Arthur C46 | EVP&Grp Pres, Medsurg &Apac | Sell | 14,011 | $75.34 | $1,055,590.14 | -41.0% | +5.7% | +39.0% | |
| May 28, 2024 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Buy | 50,000 | $5.07 | $253,475.00 | +4.8% | +24.4% | +15.8% | |
| May 28, 2024 | PODD Insulet Corp | Scannell Timothy J | Director | Sell | 3,300 | $180.90 | $596,970.00 | -7.2% | +1.6% | +82.0% | |
| May 28, 2024 | GEHC Ge Healthcare Technologies Inc. | Kass-Hout Taha | Chief Technology Officer | Sell | 3,300 | $78.70 | $259,710.00 | -4.7% | +7.3% | -9.7% | |
| May 24, 2024 | ITGR Integer Holdings Corp | Hinrichs James F.45 | Director | Sell | 9,603 | $122.44 | $1,175,772.11 | -56.4% | +0.8% | -3.5% | |
| May 24, 2024 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Buy | 18,000 | $5.19 | $93,501.00 | +1.7% | +20.2% | +14.0% | |
| May 23, 2024 | INFU Infusystem Holdings, Inc | Boyd Ralph F Jr | Director | Buy | 4,000 | $7.13 | $28,520.00 | +200.0% | -9.5% | -21.8% | |
| May 23, 2024 | IART Integra Lifesciences Holdings Corp | Essig Stuart | Exec. Chairman Of The Board | Buy | 52,641 | $28.49 | $1,499,978.97 | +12.1% | -26.2% | -56.9% | |
| May 23, 2024 | LFWD Lifeward Ltd. | Lawless Michael A | Chief Financial Officer | Buy | 2,000 | $4.97 | $9,940.40 | +93.0% | -26.1% | -74.7% | |
| May 23, 2024 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.53 | Director, 10% Owner | Buy | 100,000 | $2.60 | $260,000.00 | +0.2% | -25.7% | -64.7% | |
| May 23, 2024 | SONX Sonendo, Inc. | McGaugh John P. | SVP Operations | Sell | 10,901 | $0.09 | $990.90 | -3.0% | - | - | |
| May 23, 2024 | BSX Boston Scientific Corp | Brennan Daniel J.47 | EVP And CFO | Sell | 112,075 | $75.57 | $8,469,751.52 | -18.4% | +6.0% | +40.5% | |
| May 23, 2024 | LFWD Lifeward Ltd. | Turk Joseph E Jr | Director | Buy | 8,000 | $5.01 | $40,080.00 | +87.8% | -26.1% | -74.7% | |
| May 22, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 32,752 | $0.88 | $28,883.99 | +0.2% | +5.3% | -30.2% | |
| May 22, 2024 | SYK Stryker Corp | Fletcher Robert S | VP, Chief Legal Officer | Sell | 2,007 | $332.99 | $668,307.92 | -18.4% | +2.2% | +12.8% | |
| May 22, 2024 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 1,184 | $8.71 | $10,312.64 | -0.4% | -22.3% | -65.1% | |
| May 22, 2024 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Buy | 12,100 | $4.99 | $60,424.98 | +1.2% | +18.2% | +14.4% | |
| May 22, 2024 | INFU Infusystem Holdings, Inc | Huss Beverly A | Director | Buy | 4,300 | $6.86 | $29,485.53 | New | -15.2% | -19.0% | |
| May 22, 2024 | SONX Sonendo, Inc. | McGaugh John P. | SVP Operations | Buy | 116,500 | $0.10 | $11,545.15 | +47.1% | - | - | |
| May 22, 2024 | BSX Boston Scientific Corp | Brown Vance R | SVP, GC And Corp. Secretary | Sell | 33,043 | $75.79 | $2,504,239.29 | -33.8% | +4.1% | +38.6% | |
| May 22, 2024 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.53 | Director, 10% Owner | Buy | 600,000 | $2.57 | $1,541,795.00 | +0.4% | -28.2% | -63.1% | |
| May 21, 2024 | IART Integra Lifesciences Holdings Corp | Hill Barbara B | Director | Buy | 36,350 | $27.40 | $995,815.52 | New | -21.3% | -53.7% | |
| May 21, 2024 | LFWD Lifeward Ltd. | Jasinski Lawrence J62 | Chief Executive Officer | Sell | 1,620 | $4.91 | $7,954.20 | -1.5% | -27.0% | -76.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.